| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
1,095,971,000 |
| Market
Cap: |
17.85(B) |
| Last
Volume: |
7,790,075 |
Avg
Vol: |
10,644,293 |
| 52
Week Range: |
$7.2 - $17.09 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Teva Pharmaceutical Industries is a pharmaceutical company. Co. operates through three segments: North America, which includes the U.S. and Canada; Europe, which includes the European Union and certain other European countries; and International Markets, which includes all countries in which Co. operates other than those in Co.'s North America and Europe segments. Co.'s products include: AUSTEDO; AJOVY (anti calcitonin gene-related peptide); COPAXONE; BENDEKA and TREANDA; ProAir HFA; ProAir RespiClick; QVAR; QVAR RediHaler; ProAir Digihaler; ArmonAir Digihaler; AirDuo Digihaler; BRALTUS®; CINQAIR/CINQAERO; and AirDuo RespiClick.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
413,005 |
692,562 |
782,410 |
1,318,709 |
| Total Sell Value |
$5,594,378 |
$9,229,412 |
$10,028,649 |
$15,217,565 |
| Total People Sold |
7 |
8 |
8 |
10 |
| Total Sell Transactions |
12 |
15 |
18 |
32 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Daniell Richard |
Exec. VP, European Commercial |
• – – |
2022-02-09 |
4 |
AS |
$9.06 |
$119,010 |
D/D |
(13,135) |
20,280 |
|
-15% |
|
| Daniell Richard |
Exec. VP, European Commercial |
• – – |
2022-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,135 |
33,415 |
|
- |
|
| Schultz Kare |
President and CEO |
• • – |
2021-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
180,000 |
1,040,582 |
|
- |
|
| Inbar Galia |
See RemarksOfficer |
• – – |
2021-08-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,828 |
|
-13% |
|
| Shani Eli |
EVP,Global Marketing&Portfolio |
• – – |
2021-08-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,091 |
|
-13% |
|
| Fridriksdottir Hafrun |
Executive VP, Global R&D |
• – – |
2021-08-10 |
4 |
S |
$9.95 |
$506,021 |
D/D |
(50,860) |
41,412 |
|
19% |
|
| Peres Nechemia Jacob |
Director |
– • – |
2021-06-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,668 |
44,286 |
|
- |
|
| Nisen Perry |
Director |
– • – |
2021-06-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,668 |
44,286 |
|
- |
|
| Elstein Amir |
Director |
– • – |
2021-06-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,668 |
2,042,934 |
|
- |
|
| Mignone Roberto |
Director |
– • – |
2021-06-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,668 |
44,286 |
|
- |
|
| Crane Rosemary A |
Director |
– • – |
2021-06-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,668 |
52,218 |
|
- |
|
| Vergis Janet S. |
Director |
– • – |
2021-06-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,668 |
12,668 |
|
- |
|
| Satchi-Fainaro Ronit |
Director |
– • – |
2021-06-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,668 |
36,330 |
|
- |
|
| Lieberman Gerald M |
Director |
– • – |
2021-06-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,668 |
54,628 |
|
- |
|
| Barer Sol J |
Director |
– • – |
2021-06-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,565 |
317,563 |
|
- |
|
| Halfon Jean Michel |
Director |
– • – |
2021-06-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,668 |
49,228 |
|
- |
|
| Lieberman Gerald M |
Director |
– • – |
2021-06-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,041 |
41,960 |
|
- |
|
| Crane Rosemary A |
Director |
– • – |
2021-06-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,041 |
39,550 |
|
- |
|
| Satchi-Fainaro Ronit |
Director |
– • – |
2021-06-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,041 |
23,662 |
|
- |
|
| Nisen Perry |
Director |
– • – |
2021-06-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,041 |
31,618 |
|
- |
|
| Elstein Amir |
Director |
– • – |
2021-06-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,041 |
2,030,266 |
|
- |
|
| Mignone Roberto |
Director |
– • – |
2021-06-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,041 |
31,618 |
|
- |
|
| Halfon Jean Michel |
Director |
– • – |
2021-06-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,041 |
36,560 |
|
- |
|
| Peres Nechemia Jacob |
Director |
– • – |
2021-06-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,041 |
31,618 |
|
- |
|
| Barer Sol J |
Director |
– • – |
2021-06-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,565 |
294,998 |
|
- |
|
524 Records found
|
|
Page 8 of 21 |
|
|
0.01 (0.06%) 
